维普中文期刊产品整合服务
58篇 您的检索式:作者名="Ruppert AS"
    题名 作者 年代 出处 被引量
1Repetitive cycles of high dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16:16)(p13:q22): results from CALGB 8461显示文摘Byrd JC Ruppert AS Mr 6 zek K 2004J Clin Oncol2004,22,6:1
2Phase Ⅱ study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk disease 显示文摘Lin TS Ruppert AS Johnson AJ 2009J Clin Oncol2009,27,35:1
3Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv and t (8;21):a cancer and Leukemia Group B Study显示文摘Paschka P Marcucci G Ruppert AS 2006J Clin Oncol2006,24,24:1
4Adverse prognostic significance of kIT mutations in adult acute myeloid leukemia with iriv ( 16 ) and t ( 8 ; 21 ) : a Cancer and Leukemia Group B Study 显示文摘Paschka P Marcucci G Ruppert AS 2006J Clin Oncol2006,24,24:1
5BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics:a Cancer and Leukemia Group B Study显示文摘Baldus CD Tanner SM Ruppert AS 2003Blood2003,102,5:1
6High BAALC expression associates with other molecular prognostic markers,poor outcome,and a distinct gene expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia:a Cancer and Leukemia Group B(CALGB) study显示文摘Langer C Radmacher MD Ruppert AS 2008Blood2008,111,11:1
7A dose escalation feasibility study of lenalidomide for treatment of symptomatic,relapsed chronic lymphocytic leukemia显示文摘Maddocks K Ruppert AS Browning R 2014Leuk Res2014,38,:1
8Overexpression of the ETS-related gene,ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study显示文摘Marcucci G Baldus CD Ruppert AS 2005J Clin Oncol2005,23,36:1
9Overexpression of the ETS-related gene,ERG,predicts a worse outcome in acute myeloid leukemia with normal karyotype:a Cancer and Leukemia Group B study 显示文摘Marcucci G Baldus CD Ruppert AS 2005J Clin Oncol2005,23,:1
10Adverse prognostic sig- nifi cance of KIT mutations in adult acute myeloid leukemia with inv (16) and t(8;21) : a Cancer and Leukemia Group B Stud显示文摘Pasehka P Marcucci G Ruppert AS 2006J Clin Onco12006,24,24:1
11Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a cancer and leukemia groupBstudy显示文摘Farag SS Ruppert AS Mr6zek K 2004Int J Oncol2004,25,1:1
12High BAALC expression associates with other molecular prognostic markers in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study显示文摘Langer C Radmacher MD Ruppert AS 2008Blood2008,111,11:1
13BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics:a Cancer and Leukemia Group B Study显示文摘Baldus CD Tanner SM Ruppert AS 2003Blood2003,102,5:1
14Prognostic factors and outcome of core binding factor acute mye- loid leukemia patients with t(8;21) differ from those of patients with inv (16):a Cancer and LeukemiaGroup B study显示文摘Marcucci G Mr6zek K Ruppert AS 2005J Clin Oncol2005,23,57:1
15FLT3 D835/ I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal aeute myeloid leukemia lacking FLT3 internal tandem duplications 显示文摘Whitman SP Ruppert AS Radmacher MD 2008Blood2008,111,3:1
16FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications显示文摘Whitman SP Ruppert AS Radmacher MD 2008Blood2008,111,3:1
17Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemi- a:a cancer and leukemia group B study 显示文摘Paschka P Marcucci G Ruppert AS 2008Clin Oncol2008,26,28:1
18Outcome of induction and postremission therapy in younger aduhs with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study显示文摘FARAG SS RUPPERT AS MRO' ZEK K 2005J Clin Oncol2005,23,:1
19High BAALC expression associates with other molecular prognostic markers, poor outcome and a distinct gene-expression signature in cytogeneticaUy normal acute myeloid leukemia: a cancer and leukemia group B (CALGB) study显示文摘LANGER C RADMACHER MD RUPPERT AS 2008Blood2008,,:1
20Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8; 21) differ from those of patients with inv(6):a Cancer and Leukemia Group B study显示文摘Marcucci G Mr6zek K Ruppert AS 2005J Clin Oncol2005,23,24:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费